E3 PreliminaryModerate confidencePEM unclearCross-SectionalPeer-reviewedMachine draft
Decreased tryptophan availability but normal post-synaptic 5-HT2c receptor sensitivity in chronic fatigue syndrome.
Vassallo, C M, Feldman, E, Peto, T et al. · Psychological medicine · 2001 · DOI
Quick Summary
This study examined whether people with ME/CFS have oversensitive serotonin receptors in the brain, which could explain some of their symptoms. Researchers gave patients and healthy people a drug that directly activates serotonin receptors and measured the response. They found that both groups responded similarly, suggesting the problem in ME/CFS is not overly sensitive receptors but rather increased serotonin activity from nerve cells themselves. Interestingly, people with ME/CFS had lower levels of tryptophan (a building block for serotonin) in their blood.
Why It Matters
Understanding the biological basis of serotonin dysfunction in ME/CFS could guide targeted treatments. This study narrows the mechanism by showing the problem lies upstream in serotonin-producing neurons rather than in the receptors that receive the signal, potentially redirecting therapeutic approaches.
Observed Findings
- Post-synaptic 5-HT2c receptor sensitivity (measured by mCPP-induced prolactin elevation) was equivalent in CFS patients and healthy controls.
- Slow-wave sleep suppression in response to mCPP did not differ between CFS and control groups.
- Plasma free tryptophan levels were significantly decreased in CFS patients compared to controls.
- Fenfluramine produces an exaggerated prolactin response in CFS (from prior literature), but mCPP does not.
Inferred Conclusions
- The increased prolactin response to fenfluramine in CFS is likely due to elevated presynaptic serotonin release rather than heightened post-synaptic receptor sensitivity.
- The serotonin abnormality in CFS is unlikely to result from increased peripheral tryptophan availability to the brain.
- Serotonergic neuronal function is altered in CFS in a way that dissociates from receptor hypersensitivity.
Remaining Questions
- What causes the decrease in free tryptophan in CFS, and does this contribute to serotonin dysfunction?
- What is the functional consequence of increased presynaptic serotonin activity on CFS symptoms such as fatigue and cognitive impairment?
- Does normalizing tryptophan availability improve serotonergic function or symptoms in CFS?
What This Study Does Not Prove
This study does not establish whether the serotonin abnormality is a cause of ME/CFS symptoms or a consequence of the illness. It also does not explain why tryptophan is low or whether increasing tryptophan would improve symptoms. The findings are correlational and limited to measuring prolactin and sleep responses in a laboratory setting.
Tags
Symptom:Unrefreshing SleepFatigue
Biomarker:Blood Biomarker
Method Flag:Weak Case DefinitionSmall SampleExploratory Only
Metadata
- DOI
- 10.1017/s0033291701003580
- PMID
- 11352361
- Review status
- Machine draft
- Evidence level
- Early hypothesis, preprint, editorial, or weak support
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →